Trxade Group (MEDS)
NASDAQ:MEDS
Holding MEDS?
Track your performance easily

Trxade Group (MEDS) Technical Analysis

150 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
5Neutral
15Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Trxade Group’s (MEDS) Moving Averages Convergence Divergence (MACD) indicator is -0.51, suggesting Trxade Group is a Sell.
Trxade Group’s (MEDS) 20-Day exponential moving average is 7.38, while Trxade Group’s (MEDS) share price is $7.24, making it a Sell.
Trxade Group’s (MEDS) 50-Day exponential moving average is 8.36, while Trxade Group’s (MEDS) share price is $7.24, making it a Sell.

Trxade Group (MEDS) Pivot Points

Sep 20, 2024, 04:45 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.11
6.48
6.77
7.14
7.44
7.81
8.10
Fibonacci
6.48
6.73
6.89
7.14
7.40
7.55
7.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Trxade Group (MEDS) Moving Averages

Sep 20, 2024, 04:45 AM
Period
Simple
Exponential
MA5
7.09Sell
7.04Sell
MA10
6.90Sell
7.08Sell
MA20
7.34Sell
7.38Sell
MA50
9.69Sell
8.36Sell
MA100
8.63Sell
8.48Sell
MA200
7.31Sell
7.17Sell
Trxade Group’s (MEDS) 10-Day exponential moving average is 7.08, while Trxade Group’s (MEDS) share price is $7.24, making it a Sell.
Trxade Group’s (MEDS) 100-Day exponential moving average is 8.48, while Trxade Group’s (MEDS) share price is $7.24, making it a Sell.
Trxade Group’s (MEDS) stock price is $7.24 and Trxade Group’s (MEDS) 50-day simple moving average is 9.69, creating a Sell signal.
Trxade Group’s (MEDS) stock price is $7.24 and Trxade Group’s (MEDS) 100-day simple moving average is 8.63, creating a Sell signal.
Trxade Group’s (MEDS) stock price is $7.24 and Trxade Group’s (MEDS) 200-day simple moving average is 7.31, creating a Sell signal.

Trxade Group (MEDS) Technical Indicators

Sep 20, 2024, 04:45 AM
Name
Value
Implied Action
RSI (14)
41.86
Neutral
STOCH (9,6)
43.52
Neutral
STOCHRSI (14)
40.56
Neutral
MACD (12,26)
-0.51
Sell
ADX (14)
9.42
Buy
Williams %R
-70.06
Buy
CCI (14)
-57.43
Neutral
ATR (14)
0.83
-
Ultimate Oscillator
45.51
Neutral
ROC
-10.62
Sell
Trxade Group’s (MEDS) Relative Strength Index (RSI) is 41.86, creating a Neutral signal.
Trxade Group’s (MEDS) Trend Strength Indicator (ADX) is 9.42, creating a Buy signal.
Trxade Group’s (MEDS) Commodity Channel Index (CCI) is -57.43, creating a Neutral signal.
Trxade Group’s (MEDS) Price Rate of Change (ROC) is -10.62, creating a Sell signal.

FAQ

Is MEDS a Buy, Hold, or Sell?
Based on MEDS’s technical indicators, MEDS is a Strong Sell.
    What is MEDS’s RSI (14)?
    MEDS’s RSI (14) is 41.86, which suggests MEDS is a Neutral.
      What is MEDS’s MACD?
      MEDS’s MACD is -0.51, which suggests MEDS is a Sell.
        What is MEDS’s 5-day moving average?
        MEDS’s 5-day moving average is 7.09, which suggests MEDS is a Sell.
          What is MEDS’s 20-day moving average?
          MEDS 20-day moving average is 7.34, which suggests MEDS is a Sell.
            What is MEDS’s 50-day moving average?
            MEDS’s 50-day moving average is 9.69, which suggests MEDS is a Sell.
              What is MEDS’s 200-day moving average?
              MEDS’s 200-day moving average is 7.31, which suggests MEDS is a Sell.
                What is MEDS’s Williams % R (14)?
                MEDS’s Williams % R (14) is -70.06, which suggests MEDS is a Buy.
                  What is MEDS’s CCI (14)?
                  MEDS’s CCI (14) is -57.43, which suggests MEDS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis